Skip to main content
. 2019 Apr 20;9(4):e027797. doi: 10.1136/bmjopen-2018-027797

Table 5.

Comparison of survival between participants in the cohort and non-participants*

Estimated cumulative survival probabilities by year from diagnosis (95% CI)
Non-participants BRIGHTLIGHT cohort
1 year 0.98 (0.97 to 0.98) 0.98 (0.97 to 0.99)
2 years 0.95 (0.94 to 0.96) 0.92 (0.91 to 0.94)
3 years 0.93 (0.92 to 0.94) 0.89 (0.87 to 0.91)
4 years 0.92 (0.91 to 0.93) 0.88 (0.85 to 0.90)

Log rank test p value <0.0001.

*Non-participants were young people diagnosed in the same time frame as the BRIGHTLIGHT cohort identified by the National Cancer Registration and Analysis Service who were not part of BRIGHTLIGHT.